Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sivalokanathan Sarveswaran"'
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122805 (2015)
Castration-resistant prostate cancer (CRPC) is a major clinical challenge for which no cure is currently available primarily because of the lack of proper understanding about appropriate molecular target(s). Previously we observed that inhibition of
Externí odkaz:
https://doaj.org/article/96cb1b35b00841eab950142097751488
Supplementary Figure 1-chemical structures of Wedelolactone and Enzalutamide.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49dd3cce49194ec28a1c86ca173ced6f
https://doi.org/10.1158/1535-7163.22506015
https://doi.org/10.1158/1535-7163.22506015
Publikováno v:
Oncotarget
The cancer stem cell (CSC) concept suggests that neoplastic clones are maintained exclusively by a rare group of cells possessed with stem cell properties. CSCs are characterized by features that include self-renewal, pluripotency and tumorigenicity,
The c-Myc gene encodes an oncoprotein transcription factor that is frequently upregulated in almost all cancer types and is the subject of intense investigation for management of cancer because of its pleiotropic effects controlling a spectrum of cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8213d750d817c22b2423c57016064c9
https://europepmc.org/articles/PMC5096967/
https://europepmc.org/articles/PMC5096967/
Publikováno v:
Cancer Letters. 291:167-176
MK591 is a synthetic compound which specifically inhibits the activity of 5-Lox and is currently under development for the treatment of asthma. We observed that human prostate cancer cells treated with MK591 undergo apoptosis within hours of treatmen
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122805 (2015)
PLoS ONE
PLoS ONE
Castration-resistant prostate cancer (CRPC) is a major clinical challenge for which no cure is currently available primarily because of the lack of proper understanding about appropriate molecular target(s). Previously we observed that inhibition of
Autor:
Rosalie C. Sears, Dhananjay Chitale, Jagadananda Ghosh, Sivalokanathan Sarveswaran, Debrup Chakraborty
Myc is up-regulated in almost all cancer types and is the subject of intense investigation because of its pleiotropic effects controlling a broad spectrum of cell functions. However, despite its recognition as a stand-alone molecular target, developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3e69986659bc6de1acaa8292618b7d
https://europepmc.org/articles/PMC4335236/
https://europepmc.org/articles/PMC4335236/
Publikováno v:
International Journal of Oncology
Emerging studies indicate that metabolism of arachidonic acid through the 5-lipoxygenase (5-Lox) pathway plays a critical role in the survival of prostate cancer cells raising the possibility that 5-Lox can be targeted for an effective therapy of pro
Autor:
Zongxiang Zhou, Joshua Liroff, Alexander Yu. Nikitin, Jagadananda Ghosh, Sivalokanathan Sarveswaran
Publikováno v:
International Journal of Oncology. 36
Supra-nutritional selenium supplementation has emerged as an attractive new approach to intervene in a range of human cancers, in particular prostate cancer. However, scanty information is currently available on molecular mechanisms underlying seleni
Publikováno v:
Cancer Research. 74:2702-2702
Background: Prostate cancer cells continuously generate 5(S)-HETE series of metabolites from arachidonic acid via 5-lipoxygenase (5-Lox) activity, and inhibition of 5-Lox blocks production of metabolites and triggers apoptosis both in androgen-sensit